iiinova — where your digital self keeps evolving

rouchelles.bsky.social

@rouchelles.bsky.social

rouchelles.bsky.social @rouchelles.bsky.social · 19/01/2026

Thank you Elisa Martini for featuring the IVORY trial published in @natmed.nature.com in Nature Portfolio’s Nature CVR 🫀 Main paper: rdcu.be/eX8W3 Commentary: rdcu.be/eYyG6 @jch403.bsky.social @ziadmallat.bsky.social @18fdg.bsky.social @ivorytrial.bsky.social @mallatlab.bsky.social

044

rouchelles.bsky.social @rouchelles.bsky.social · 12/01/2026

The IVORY trial was published in Nature Medicine last week. rdcu.be/eX8W3 This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a ⬆️ Regulatory T cells ⬇️ Arterial inflammation 🔥 ⬇️ trend in adverse cardiovascular outcomes ❤️‍🔥 at 2 years

Commissioned artwork for the IVORY trial by Shaanea Mendis. Depicting regulatory T cells in blue which are calming down inflammation in blood vessels after heart attacks.

111